The Latest Cardiac and Vascular News
Strengthens the Potential for Improved Patient Outcomes through Improvements in the Quality of Anticoagulation, Enhancing Hemocompatibility in HeartMate 3™ LVAD patients March 04, 2025 08:00 AM Eastern Standard Time PONTE VEDRA, Fla.–(BUSINESS WIRE)–Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapeutics, with […]
Collaboration Expands Access to AI Technologies for Early Detection and Personalized Treatment of Coronary Artery Disease SAN FRANCISCO, CA and DENVER, CO—[March 4, 2025]—Bunkerhill Health, a leader in AI-enabled early disease detection, and Cleerly, a pioneer in advanced cardiovascular imaging, announced today a strategic partnership to expand access to […]
The first patient implanted at Brown University Health marks the expansion of the study to multiple clinical sites RESTORE aims to generate the data necessary to demonstrate the long-term safety and efficacy of DBS+Rehab in stroke patients to support marketing approval CLEVELAND, March 4,…
Mr. Paul Mullen Most Recently Served as the Director of Sales at Inari Medical which was Acquired by Stryker Corporation Earlier This Year
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease SANTA CLARA, Calif., March 4, 2025 /PRNewswire/ — Today, Shockwave Medical, Inc., part of Johnson…
WARRINGTON, Pa., March 04, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, is pleased to announce that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. application number 18/150,870 directed to “ISTAROXIME-CONTAINING INTRAVENOUS FORMULATION FOR THE TREATMENT OF ACUTE HEART FAILURE.”
MENLO PARK, Calif., March 4, 2025 /PRNewswire/ — Ajax Health, a KKR-backed medical device platform, today announced the formation of a new entity, FlowMod. The new organization is the result of a collaboration between Boston Scientific Corporation, Ajax Health, and KKR, utilizing…
IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company specializing in innovative therapies for vascular disease, is pleased to announce the appointment of Andrew Davis as its new Chief Commercial Officer, effective immediately. “I am excited to join Endologix at such a pivotal moment” Post this Andrew joins […]
BOSTON–(BUSINESS WIRE)–Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has added several senior members to its clinical and commercial teams. The appointments have been made as Elucid continues preparations for the commercial launch of its FDA-cleared PlaqueIQTM image analysis […]
BOSTON–(BUSINESS WIRE)–Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treating heart valves, announced today the first commercial procedures with ShortCut™ – the world’s first dedicated leaflet modification device, enabling valve-in-valve (ViV) Transcatheter Aortic Valve Replacement (TAVR) procedures in patients at risk of coronary obstruction. The news […]
